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In the present paper we studied the effect of urodilatin and atrial natriuretic peptide (ANP) on the proximal tubule Na+-ATPase and
(Na+K+)ATPase activities. Urodilatin and ANP inhibit the Na+-ATPase activity but not the (Na+K+)ATPase activity. Maximal effect was
observed at a concentration of 10 11 M for both peptides. In this condition, the enzyme activity decreases from 10.8F 1.6 (control) to
5.7F 0.9 or 6.1F 0.7 nmol Pi mg 1 min 1 in the presence of urodilatin or ANP, respectively. This effect was completely reversed by 10 6
M LY83583, a guanylyl cyclase inhibitor, and mimicked by 10 nM cGMP. Furthermore, both ANP and urodilatin increase cGMP production
by 33% and 49%, respectively. This is the first demonstration that it was shown that urodilatin and ANP directly modulate primary active
sodium transport in the proximal tubule. The data obtained indicate that this effect is mediated by the activation of the NPR-A/guanylate
cyclase/cGMP pathway.
D 2003 Elsevier B.V. All rights reserved.Keywords: Na+-ATPase; Urodilatin; ANP; Furosemide; Proximal tubule1. Introduction
Modulation of Na+ reabsorption in the kidney is critical
for maintenance of the extracellular volume and for long-
term regulation of blood pressure [1,2]. Several compounds
are involved in this process such as urodilatin and atrial
natriuretic peptide (ANP) [3,4]. ANP is a 28-amino-acid
peptide described initially to be produced in the atrial
cardiomyocytes [4,5] Actually, it is known that ANP can
be produced in several tissues including renal tubules [6,7].
Urodilatin is a 32-amino-acid peptide similar to ANP,
extended by four amino acids in the NH2-terminal portion
(ANP 95–126) [8–10]. This peptide is produced in renal
distal segments where it may act as a paracrine factor
modulating the function of the different segments of the
nefron [6,9]. It has been shown that ANP and urodilatin
increase renal sodium excretion being this effect correlated,
in part, to the inhibition of tubular sodium transport [4,6].
Approximately 70% of the filtered sodium is reab-
sorbed in the proximal tubule and consequently small0005-2736/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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for overall body sodium metabolism. The transcellular
sodium reabsorption in the proximal tubule involves two
primary active transporters: the ouabain-sensitive
(Na+K+)ATPase and the ouabain-insensitive, furosemide-
sensitive Na+-ATPase [11,12]. These enzymes are located
in basolateral membranes and they are involved in the
genesis of the Na+ electrochemical gradient [11]. The Na+-
ATPase is about 10 times less active than the (Na+K+)AT-
Pase [12], which suggests that this enzyme may be in-
volved in fine tuning, whereas the (Na+K+)ATPase is
responsible for most of the Na+ reabsorption in the proximal
tubule.
Although urodilatin and ANP play an important role in
the regulation of renal sodium excretion nothing is known
about their mechanisms of action along the nephron. It
was observed that ANP and urodilatin modulate renal
active Na+ transport [6,13], although it is not known if
this effect, in proximal tubule, is due to direct modulation
of primary active sodium transporters or not [6]. Therefore,
the aim of this study was to examine the possible effects
of urodilatin and ANP on the Na+-ATPase and (Na+K+)AT-
Pase activities of isolated basolateral membranes from
proximal tubule.
C. Caruso-Neves et al. / Biochimica et Biophysica Acta 1660 (2004) 93–98942. Materials and methods
2.1. Materials
ATP, ouabain, furosemide, EGTA, HEPES, sodium
azide, ANP, C-type natriuretic peptide and brain natriuretic
peptide were purchased from Sigma Chemical Co., St.
Louis, MO, USA. Percoll was from Pharmacia Biotech,
Uppsala, Sweden. All other reagents were of the highest
purity available. [32P]Pi was obtained from the Institute of
Energetic and Nuclear Research, Sa˜o Paulo, SP, Brazil.
All solutions were prepared with deionized glass-dis-
tilled water. [g-32P]ATP was prepared as described by Maia
et al. [14].
2.2. Preparation of isolated basolateral membranes from
proximal tubule
Cortex homogenates and basolateral membranes were
prepared from adult pig kidney. The kidneys were removed
immediately after the animal’s death and maintained in cold
solution containing ( mM): sucrose 250, HEPES–Tris (pH
7.6) 10, EDTA 2 and PMSF 1 [8–10]. Thin slices of the
cortex (cortex-corticis) were removed with a scalpel. After
dissection, slices were homogenized in the same cold
solution with a Teflon and glass homogenizer. The homog-
enate was centrifuged for 10 min at 3000 rpm in a SCR20B
centrifuge using an RP12-2 rotor at 4 jC. The supernatant
was collected and stored at  4 jC. The fraction containing
the basolateral membranes was isolated by the Percoll
gradient method [12]. The membrane preparation was
resuspended in 250 mM sucrose at a final concentration of
4–10 mg of protein ml 1 and stored at  4 jC. The
specific activity of the basolateral-marker (Na+K+)ATPase
was eightfold enriched when compared with that measured
in the initial preparation of cortex homogenate. The same
enrichment was observed to the Na+-ATPase specific activ-
ity. On the other hand, the alkaline phosphatase and 5V-
nucleotidase specific activities, markers of luminal mem-
brane, were only 1.2- and 0.25-fold enriched, respectively.
Residual contamination with other subcellular membrane
markers was minimal. The succinate dehydrogenase specific
activity (a marker for mitochondrial contamination), acid
phosphatase specific activity (a marker for lysosomal mem-
branes) and glucose-6-phosphatase specific activity (a mark-
er for endoplasmic reticulum) were decreased by 95%, 90%
and 94%, respectively [15,16].
2.3. Measurement of ATPase activity
The composition of the standard assay medium (0.1 ml)
was: 10 mM MgCl2; 5 mM [g-
32P]ATP; 20 mM HEPES–
Tris (pH = 7.0); 1 mM EGTA; and 90 mM NaCl; 10 mM
Azida for the measurement of the Na+-ATPase activity or
120 mM NaCl and 30 mM KCl for the measurement of the
(Na+K+)ATPase activity, except as noted in figure legends.ATPase activity was measured according to the method
described by Grubmeyer and Penefsky [17]. The reaction
was started by the addition of cortex homogenate or
isolated basolateral membranes to a final protein concen-
tration of 0.3–0.5 mg/ml, and stopped after 30 min by the
addition of charcoal activated by HCl (0.1 N). The [32P]Pi
released was measured in an aliquot of the supernatant
obtained after centrifugation of the charcoal suspension
for 5 min at 3000 rpm in a clinical centrifuge. Sponta-
neous hydrolysis of [g-32P]ATP was measured simulta-
neously in tubes where protein was added after the acid.
The Na+-ATPase activity was calculated from the differ-
ence between the [32P]Pi released in the absence and in
the presence of 2 mM furosemide or in the presence and
in the absence of NaCl, all conditions in the presence of 1
mM ouabain [12]. It was observed the same protein
concentrations were determined by the Folin phenol
method [18] using bovine serum albumin as standard.
Each experiment was performed in at least four indepen-
dent preparations of basolateral membranes or cortex
homogenate.
2.4. cGMP measurement
The composition of the reaction medium was: 10 mM
MgCl2; 5 mM ATP; 20 mM HEPES–Tris (pH = 7.0); 10
mM Azide; 1 mM EGTA and 90 mM NaCl. The reaction
was started by the addition of isolated basolateral mem-
branes to a final protein concentration of 0.3 mg/ml, and
stopped after 10 min by the addition of 0.9-ml ice-cold 6%
trichloroacetic acid. cGMP was measured with a commer-
cially available cGMP enzyme immunoassay (EIA) system
(Amersham, Buckinghamshire, UK), following the protocol
supplied with the kit.
2.5. Statistical analysis
Each experiment was performed in an independent
preparation of basolateral membranes or cortex homogenate.
The data were analyzed by two-way analysis of variance
(ANOVA), considering the treatments as factors. The sig-
nificance of the differences was verified by the Bonferroni
t-test. Statistical analysis was performed using absolute
values and the results were expressed in percentage of the
controlF S.E. of the means.3. Results and discussion
3.1. Effect of urodilatin and ANP on (Na+K+)ATPase and
Na+-ATPase activities
In order to avoid the effect of urodilatin and ANP on
luminal sodium transporters, all experiments were per-
formed using basolateral membranes isolated from pig
kidney proximal tubules.
Fig. 2. Na+ concentration dependence of Na+-ATPase activity in isolated
basolateral membranes of renal proximal tubule with or without peptides
(open circles). When indicated, 10 11 M urodilatin (closed circles) or
10 11 M ANP (open triangles) was added. The Na+-stimulated ATPase
activity was calculated as the difference between the ATPase activity in the
presence and absence of Na+, both in the presence of ouabain 2 mM (see
Materials and methods). Na+ concentration was increased from 2 to 120
mM. The kinetic parameters were calculated by the following equation:
v=Vmax+[S]/Km[S]. Results are expressed as meanF S.E. (n= 5).
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sodium pumps, we measured the (Na+K+)ATPase and Na+-
ATPase activities in the presence of different concentrations
of both peptides (Fig. 1). The increase in concentrations of
both peptides from 10 18 to 10 7 M inhibits the Na+-
ATPase activity in a dose-dependent manner being the
maximum effect observed at 10 11 M (Fig. 1). In this
condition, enzyme activity decreases from 10.8F 1.6 (con-
trol) to 5.7F 0.9 or 6.1F 0.7 nmol Pi mg 1 min 1 in the
presence of urodilatin or ANP, respectively. Simultaneous
addition of 10 11 M ANP and 10 11 M urodilatin does not
have an additive effect on the Na+-ATPase activity (data
not shown).
On the other hand, in the same range of concentrations,
urodilatin or ANP do not modulate the (Na+K+)ATPase
activity in basolateral membranes isolated from proximal
tubule (Fig. 1). The same lack of effect was observed in
external cortex homogenates preparation and in the pres-
ence of subsaturating Na+ concentrations (data not shown).
These data are in agreement with the observation that ANP
only inhibits the proximal tubule (Na+K+)ATPase activity
after stimulation of the enzyme with norepinephrine or
angiotensin II [19]. Taken together these data suggest that
ANP and urodilatin may play a role in counteracting the
activation of proximal tubule (Na+K+)ATPase by antina-
triuretic compounds. However, the direct effect of both
compounds cannot be ruled out since it was observed that
the modulation of the (Na+K+)ATPase depends on cell
integrity [19,20]. Further experiments are necessary to
clarify this issue.Fig. 1. Urodilatin (circles) and ANP (triangles) concentration dependence of
Na+-ATPase (open symbols) and (Na+K+)ATPase (closed symbols)
activities in isolated basolateral membranes of renal proximal tubules.
ATPase activities were measured as described in Materials and methods.
The urodilatin and ANP concentrations were increased from 10 18 to 10 7
M. Results are expressed as percentage of the control, without peptides
(square). The absolute valuesF S.E. of the Na+-ATPase and (Na+K+)AT-
Pase activities were 10.8F 1.6 and 103.1F 7.6 nmol Pi mg 1 min 1,
respectively. *Statistically significant when compared to control ( P< 0.05)
(n= 10).Fig. 2 shows the effect of 10 11 M ANP or 10 11 M
urodilatin on the Na+ concentration dependence of the Na+-
ATPase activity in the presence of 1.0 mM ouabain. The
Na+ concentration that promotes half maximal stimulation
(K0.5) was 9.6F 1.5 mM and the maximal rate (Vmax) was
13.5F 1.1 nmol Pi mg 1 min 1. Urodilatin decreases both
K0.5 and Vmax to 3.1F 0.8 mM and 5.7F 0.2 nmol Pi mg
 1
min 1, respectively. ANP decreases Vmax to 8.4F 0.4 nmol
Pi mg 1 min 1 and increases K0.5 to 22.9F 3.9 mM.
3.2. Possible involvement of guanylyl cyclase/cGMP on
inhibition of Na+-ATPase activity by urodilatin and ANP
The effect of ANP and urodilatin on renal sodium
excretion is mediated by receptors containing an intrinsic
guanylyl cyclase activity [21]. The binding of these pep-
tides to their receptor increases guanylyl cyclase activity
leading to a rise in cGMP concentration. In the next
experimental group, we verified the effect of both ANP
and urodilatin on the cGMP level (Fig. 3). The addition of
10 11 M ANP or 10 11 M urodilatin increases the cGMP
level by 33% and 49%, respectively. Furthermore, 10 6 M
LY83583, a guanylyl cyclase inhibitor, completely reverses
the inhibitory effect of ANP and urodilatin on the Na+-
ATPase activity (Fig. 4). These data agree with the obser-
vation that ANP stimulates cGMP synthesis in rat proximal
tubule [22].
Fig. 5 shows the effect of dibutyryl-cGMP (d-cGMP) on
the Na+-ATPase activity of basolateral membrane. An
increase in d-cGMP concentrations from 1 to 10 nM inhibits
the Na+-ATPase activity in a dose-dependent manner, being
the maximal effect at 10 nM. In this condition, the enzyme
Fig. 3. Changes in cGMP induced by ANP (10 11 M) and urodilatin
(10 11 M). cGMP was measured as described in Materials and methods.
Results are expressed as percentage of the control. In the control condition
the cGMP level is 6.7 pmol mg 1. *Statistically significant when compared
to control ( P < 0.05) (n= 3).
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similar and not additive to urodilatin or ANP (Fig. 5B).
The physiological actions of natriuretic peptides are
mediated by specific receptors: NPR-A, NPR-B and NPR-
C [21]. NPR-A and NPR-B present a guanylate cyclase
activity in their domains while NPR-C lacks this domain
[6,21]. It was observed that ANP and urodilatin bind
preferentially to NPR-A receptor and this receptor is
expressed in different nephron segments including proximal
tubule [7]. Our results show that ANP and urodilatin have
the same potency and affinity on the inhibition of Na+-
ATPase activity and stimulation of cGMP production. We
then postulated that urodilatin and ANP modulate theFig. 4. Reversal of the effect of urodilatin and ANP on Na+-ATPase activity
by LY83583, a guanylyl cyclase inhibitor. ATPase activity was measured as
described in Materials and methods. Results are expressed as percentage of
the control. *Statistically significant when compared to control ( P< 0.05)
(n= 6).
Fig. 5. Effect of dibutyryl-cGMP (d-cGMP) on Na+-ATPase activity in the
absence (A) or in the presence of 10 11 M urodilatin or 10 11 M ANP (B).
In panel (A) d-cGMP concentration was increased from 1 to 10 nM. ATPase
activity was measured as described in Materials and methods. Results are
expressed as percentage of the control. *Statistically significant when
compared to control ( P < 0.05) (n= 7).proximal tubule Na+-ATPase through the activation of
NPR-A/guanylate cyclase/cGMP pathway. This hypothesis
agrees with the observation that the effect of ANP and
urodilatin on renal sodium excretion is mediated by NPR-A
receptors [6].
Since the effects of ANP and urodilatin are completely
abolished by guanylate cyclase inhibitor, the possibility that
both peptides bind directly to the enzyme could be ruled out.
If the effect of cGMP on the enzyme activity is due to a
direct effect on the enzyme, such as observed in some
channels [23], or mediated by other protein such as PKG
[6], it was not determined yet. Further experiments are
necessary to clarify this issue.
In general the effects of ANP and urodilatin on the renal
sodium excretion are associated to changes in the sodium
reabsorption in the distal nephron segments [6]. It was
observed that ANP modulates the proximal tubule sodium
reabsorption, although little is known about the effects of
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we showed that urodilatin inhibits the proximal tubule Na+-
ATPase which is compatible with its effect on the renal
sodium excretion. Taken together these data indicate that the
proximal tubule Na+-ATPase is a target to the action of
urodilatin during the regulation of renal sodium excretion.
Furthermore, the observation that urodilatin and ANP have
the same effect on the proximal tubule Na+-ATPase favors
the hypothesis that urodilatin reproduces the mechanisms of
sodium transport regulation triggered by ANP [6].
It has been proposed that urodilatin is produced in distal
tubule and secreted into tubular lumen [6]. Our data show
that urodilatin is able to modulate the proximal tubule Na+-
ATPase through the interaction of basolateral receptors,
suggesting that there may be a mechanism of secretion into
the interstitial space. In this way, the urodilatin produced
could act as a paracrine compound modulating the sodium
transport in adjacent segments such as proximal tubule. This
hypothesis is supported by the following observations: (1)
systemic or intrarenal administration of urodilatin increases
the fractional renal sodium excretion [24]; (2) it has been
shown that urodilatin could bind to the same ANP receptors
[6]. Furthermore, it was observed the presence of ANP
receptors in the luminal and basolateral side of mouse
proximal tubules [25].
The Na+-ATPase was initially described by Proverbio et
al. [26,27] in aged microsomal fractions from guinea-pig
kidney cortex. They described two forms of Na+-stimulated
ATPase activity: (a) the classical ouabain-sensitive
(Na+K+)ATPase, and (b) the ouabain-insensitive Na+-
ATPase, which was sensitive to ethacrynic acid and furose-
mide. It was observed that this enzyme is located in baso-
lateral membranes of the proximal tubule and it is also
expressed in different cells of several species [11,12,28]. In
the present paper, we observed that urodilatin and ANP
selectively inhibit the Na+-ATPase of proximal tubule,
which is compatible with their effect on renal sodium
excretion. Similar results were observed in our laboratory
using angiotensins, kinins and adenosine [29–32]. Taken
together these data support the hypothesis that the ouabain-
insensitive Na+-ATPase is a primary active transport target
for compounds involved in the fine regulation of Na+
reabsorption in proximal tubule.Acknowledgements
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